The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of chemoradiation-related lymphopenia in patients with gastric and gastroesophageal cancer.
 
Daniel W Kim
No Relationships to Disclose
 
Grace Lee
No Relationships to Disclose
 
Theodore S. Hong
Consulting or Advisory Role - Merck; Novocure; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Intrinsic LifeSciences (Inst); Ipsen (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Guichao Li
No Relationships to Disclose
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; Astellas Pharma; BASF; HERON; Immuneering; Napo Pharmaceuticals; Oragenics; Oragenics; Pfizer/EMD Serono; Vector Oncology
Expert Testimony - Regents of the University of California
 
Florence Keane
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - OncLive
 
Christine Elissa Eyler
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
Jill N. Allen
No Relationships to Disclose
 
David L. Berger
No Relationships to Disclose
 
Aparna Raj Parikh
Consulting or Advisory Role - Foundation Medicine; Lilly; Natera; PureTech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); Tesaro (Inst)
 
John Mullen
No Relationships to Disclose
 
Samuel J Klempner
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - Natera
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Bristol-Myers Squibb; Foundation Medicine; Lilly; Merck; Pieris Pharmaceuticals
Speakers' Bureau - Foundation Medicine
Research Funding - BeiGene (Inst); Leap Therapeutics (Inst)
Other Relationship - NCCN
 
Jeffrey William Clark
Research Funding - Pfizer (Inst)
 
Jennifer Y Wo
No Relationships to Disclose